Kandiah Chandrakumaran
Overview
Explore the profile of Kandiah Chandrakumaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
826
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saeed A, Nesari C, Evans V, Chandrakumaran K, Cecil T, Moran B, et al.
Eur J Surg Oncol
. 2024 Dec;
51(2):109495.
PMID: 39626331
Introduction: Intraabdominal collections (IACs) are common following cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Inflammatory biomarkers and nutritional index (NI) may predict IACs. Management of IACs with image guided...
2.
Asmar M, Mortagy M, Chandrakumaran K, Cecil T, Ramage J
Curr Oncol
. 2024 Jul;
31(7):3855-3869.
PMID: 39057157
Introduction: Right hemicolectomy (RHC) remains the treatment standard for goblet cell adenocarcinoma (GCA), despite limited evidence supporting survival benefit. This study aims to explore factors influencing surgical management and survival...
3.
Mortagy M, Asmar M, Chandrakumaran K, Ramage J
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001438
Background: Neuroendocrine neoplasms (NENs) are increasing in incidence globally. Previous analysis of the UK cancer database (National Cancer Registration and Analysis Service (NCRAS)) showed a notable female survival advantage in...
4.
White B, Russell B, Remmers S, Rous B, Chandrakumaran K, Wong K, et al.
Cancers (Basel)
. 2023 Mar;
15(6).
PMID: 36980749
Pre-clinical studies have suggested sex hormone signalling pathways may influence tumorigenesis in neuroendocrine neoplasia (NEN). We conducted a retrospective, population-based study to compare overall survival (OS) between males and females...
5.
Chandrakumaran K, Carr N, Mohamed F, Cecil T, Moran B
JAMA Surg
. 2023 Mar;
158(5):522-530.
PMID: 36920381
Importance: Pseudomyxoma peritoni, a rare condition characterized by mucinous ascites and peritoneal deposits, mainly originates from a ruptured mucinous appendix tumor and is considered an indolent disease but can progress...
6.
Paisey S, Weerasuriya S, Palmer K, White B, Srirajaskanthan R, Chandrakumaran K, et al.
J Neuroendocrinol
. 2022 Dec;
34(12):e13215.
PMID: 36524462
Primary renal neuroendocrine neoplasms (NEN) are rare. We aimed to conduct a systematic review, present local cases, and analyse data from the England's National Cancer Registration and Analysis Service (NCRAS)...
7.
Welsh F, Walsh C, Chandrakumaran K, Rathnaweera W, Roy A, Needham J, et al.
HPB (Oxford)
. 2022 Oct;
25(1):63-72.
PMID: 36253269
Background: Routine chemical venous thromboembolism (VTE) prophylaxis for liver surgery remains controversial, and often delayed post-operatively due to perceived bleeding risk. This study asked whether patients undergoing hepatectomy for colorectal...
8.
White B, Rous B, Chandrakumaran K, Wong K, Bouvier C, Van Hemelrijck M, et al.
Lancet Reg Health Eur
. 2022 Sep;
23:100510.
PMID: 36176500
Background: Neuroendocrine neoplasia (NEN) incidence is rising internationally. We aimed to evaluate the epidemiology of NEN in England and examine changes in survival over time. Methods: A retrospective, population-based study...
9.
Palmer K, Weerasuriya S, Chandrakumaran K, Rous B, White B, Paisey S, et al.
Front Oncol
. 2022 Jul;
12:915028.
PMID: 35903705
Background: Goblet cell adenocarcinoma (GCA) of the appendix is a rare and aggressive tumour with varying nomenclature and classification systems. This has led to heterogeneity in published data, and there...
10.
Boyce S, James I, Rangarajan S, Curry N, Bagot C, Austin S, et al.
Res Pract Thromb Haemost
. 2022 Jun;
6(4):e12705.
PMID: 35677030
Background: Gene therapy shows promise as a potential "cure" for hemophilia A and B. Adeno-associated virus (AAV) vectors are the leading platform to deliver modified genetic code of factor VIII...